Blue Water Life Science Advisors, LP Adaptive Biotechnologies Corp Transaction History
Blue Water Life Science Advisors, LP
- $110 Million
- Q4 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 2,145,145 shares of ADPT stock, worth $17.9 Million. This represents 11.71% of its overall portfolio holdings.
Number of Shares
2,145,145
Previous 2,145,145
-0.0%
Holding current value
$17.9 Million
Previous $11 Million
17.18%
% of portfolio
11.71%
Previous 9.66%
Shares
9 transactions
Others Institutions Holding ADPT
# of Institutions
219Shares Held
148MCall Options Held
50.5KPut Options Held
48.2K-
Viking Global Investors LP30MShares$250 Million0.61% of portfolio
-
Rubric Capital Management LP New York, NY14.6MShares$122 Million1.45% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$97.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$89.3 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.42MShares$78.5 Million0.49% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.19B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...